Invesco Ltd. Allogene Therapeutics, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 120,138 shares of ALLO stock, worth $386,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,138

Previous 120,683 0.45%

Holding current value

$386,844

Previous $539,000 48.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.23 - $4.38 $1,215 - $2,387	-545 Reduced 0.45%	120,138 $279,000
Q1 2024 May 14, 2024	BUY	$2.92 - $5.63 $54,624 - $105,320	18,707 Added 18.34%	120,683 $539,000
Q4 2023 Feb 12, 2024	BUY	$2.28 - $3.5 $19,297 - $29,624	8,464 Added 9.05%	101,976 $327,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $3,937 - $7,402	1,242 Added 1.35%	93,512 $296,000
Q2 2023 Aug 11, 2023	SELL	$4.53 - $6.74 $12,403 - $18,454	-2,738 Reduced 2.88%	92,270 $458,000
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $25,588 - $42,700	5,201 Added 5.79%	95,008 $469,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $11.11 $2,158 - $4,266	-384 Reduced 0.43%	89,807 $564,000
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $5.24 Million - $8.78 Million	-507,974 Reduced 84.92%	90,191 $974,000
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $3.5 Million - $6.33 Million	515,612 Added 624.58%	598,165 $6.82 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $346,942 - $693,432	45,352 Added 121.91%	82,553 $751,000
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $27,454 - $51,271	2,091 Added 5.96%	37,201 $556,000
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $90,364 - $118,879	-4,301 Reduced 10.91%	35,110 $902,000
Q2 2021 Aug 17, 2021	BUY	$23.49 - $35.8 $428,363 - $652,848	18,236 Added 86.12%	39,411 $1.03 Million
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $21,869 - $33,088	848 Added 4.17%	21,175 $747,000
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $199,295 - $343,081	7,896 Added 63.52%	20,327 $513,000
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $5,698 - $7,912	-176 Reduced 1.4%	12,431 $468,000
Q2 2020 Aug 14, 2020	SELL	$18.39 - $54.04 $20,651 - $60,686	-1,123 Reduced 8.18%	12,607 $539,000
Q1 2020 May 15, 2020	BUY	$18.22 - $28.25 $250,160 - $387,872	13,730 New	13,730 $267,000

Others Institutions Holding ALLO

# of Institutions

172

Shares Held

130M

Call Options Held

94.3K

Put Options Held

112K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $463M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account